aod9604 fda approved AOD-9604 5mg (Spray) – Modified Aminos AOD-9604 Vial — Lyophilized, HPLC
Description
Various secondary alkyl halides are then readily attacked by the modified B 12s to give the corresponding stable cobalamin analogs
Allergic reactions (rash, itching, swelling)
Inadequate initial treatment may result in suboptimal responses and persistent symptoms
After that, its given monthly
These medications reduce gastric acid production, which is necessary for releasing dietary vitamin B12 from food proteins and for maintaining the stability of the B12-intrinsic factor complex
